Aperio Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.03M | Buy |
8,287
+2,324
| +39% | +$287K | ﹤0.01% | 1574 |
|
|
2020
Q3 | $581K | Buy |
5,963
+1,494
| +33% | +$146K | ﹤0.01% | 1740 |
|
|
2020
Q2 | $697K | Buy |
4,469
+578
| +15% | +$90.1K | ﹤0.01% | 1595 |
|
|
2020
Q1 | $562K | Buy |
3,891
+1,363
| +54% | +$197K | ﹤0.01% | 1587 |
|
|
2019
Q4 | $517K | Buy |
+2,528
| New | +$517K | ﹤0.01% | 1778 |
|
|
2019
Q3 | – | Sell |
-2,316
| Closed | -$219K | – | 2854 |
|
|
2019
Q2 | $219K | Buy |
+2,316
| New | +$219K | ﹤0.01% | 2146 |
|